Skip to main content
丹娜生物 logo

丹娜生物 — Investor Relations & Filings

Ticker · 920009 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 61 across all filing types
Latest filing 2026-04-07 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920009

About 丹娜生物

https://www.dynamiker.com/

Dynamiker Biotechnology specializes in the research, development, and manufacturing of in vitro diagnostic (IVD) solutions, focusing on the early detection and monitoring of invasive fungal diseases (IFD). The company offers a comprehensive diagnostic portfolio targeting pathogens such as Aspergillus, Candida, Cryptococcus, and Pneumocystis jirovecii. Its core product lines include (1-3)-β-D-glucan (G test), Galactomannan (GM test), and Cryptococcal Antigen (CrAg) assays, utilizing methodologies like ELISA, lateral flow, and molecular diagnostics. These products are designed to provide rapid, sensitive, and specific results for clinical decision-making. Dynamiker maintains international quality standards and certifications, supporting its commitment to improving diagnostic accuracy and patient management in global healthcare settings.

Recent filings

Filing Released Lang Actions
2025年度独立董事述职报告（涂红）
Board/Management Information Classification · 95% confidence The document is titled as the "2025年度独立董事述职报告（涂红）" which translates to "2025 Annual Independent Director's Work Report (Tu Hong)". It is a detailed report by an independent director about her duties, attendance, and activities during the year 2025. The content includes descriptions of board meetings attended, committee work, communication with shareholders, supervision of financial reports, and other governance-related activities. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an announcement or proxy solicitation. It is a management/board related report focusing on the independent director's role and performance. This fits best under Board/Management Information (MANG) as it relates to board member duties and disclosures. The document length is over 5,000 characters and contains substantive content, so it is not a mere announcement or certification. Therefore, the classification is MANG with high confidence.
2026-04-07 Chinese
招商证券股份有限公司关于丹娜（天津）生物科技股份有限公司2025年度募集资金存放、管理与实际使用情况的专项核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the 2025 annual fundraising funds deposit, management, and actual usage for a company that recently issued shares and listed on the Beijing Stock Exchange. It includes specifics on the amount raised, timing, storage, usage, adjustments to investment projects, cash management of idle funds, and compliance with relevant securities laws and regulations. It also contains accountant verification and sponsor institution opinions on the fundraising funds management. The document is substantive, over 15,000 characters, and contains detailed financial and management information about the fundraising activities and their compliance. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. It is not an announcement of a report, nor a general regulatory filing, nor an annual or interim report. Therefore, the correct classification is CAP with high confidence.
2026-04-07 Chinese
2025年年度报告
Annual Report Classification · 100% confidence The document is titled '年度报告 2025' which translates to 'Annual Report 2025'. It contains detailed sections typical of an annual report such as company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management information, industry information, corporate governance, and financial accounting reports. The document includes audited financial data, management discussion, risk factors, and comprehensive financial statements. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of an auditor's unqualified opinion further confirms this is a full annual report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2025
2026-04-07 Chinese
2025年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as an "年度报告摘要" which translates to "Annual Report Summary" and references the full annual report for comprehensive details. It includes detailed financial data for the years 2023, 2024, and 2025, such as total assets, net profit, earnings per share, and shareholder information. It also mentions an audit report with an unqualified opinion from an accounting firm, which is typical for annual reports. The document is lengthy (15,000 characters) and contains substantive financial and operational information, not just an announcement or a brief summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2025
2026-04-07 Chinese
董事会关于独立董事2025年度独立性自查情况的专项报告
Board/Management Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence self-assessment of independent directors for the year 2025. It references regulatory rules about independent directors and confirms their compliance and independence status. The content is focused on governance and board-related information rather than financial results, audit, or shareholder voting. The document length is short (1019 characters) and it is a formal announcement of a board-related matter. Therefore, it fits best under Board/Management Information (MANG), which covers announcements about board members and their status.
2026-04-07 Chinese
2025年度独立董事述职报告（林涛）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2025 by Lin Tao, an independent director of the company. It details the director's activities, attendance at board and committee meetings, oversight of financial and governance matters, communication with shareholders, and compliance with relevant laws and regulations. The content focuses on the director's duties and observations rather than presenting full financial statements or audit results. It is a detailed report on board/management information, specifically the independent director's report on their duties and governance role during the year. It is not an annual report (10-K), audit report (AR), or regulatory filing (RNS). The document length (5518 characters) and detailed content support classification as Board/Management Information (MANG).
2026-04-07 Chinese

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.